Cocrystal pharma to participate in the h.c. wainwright global investment conference

Bothell, wash., sept. 05, 2023 (globe newswire) -- cocrystal pharma, inc. (nasdaq: cocp) (“cocrystal” or the “company”), a clinical-stage biopharmaceutical company dedicated to developing novel small molecule antiviral therapeutics, announces that management will participate in the h.c. wainwright 25th annual global investment conference being held september 11-13, 2023. a webcast of the cocrystal presentation will be available on the ir calendar section of the company's website beginning monday, september 11 at 7:00 a.m. eastern time.
COCP Ratings Summary
COCP Quant Ranking